Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) has announced the appointment of Veet Misra, PhD, as chief financial officer (CFO), and Eric Huang as senior vice president (SVP) of global corporate development and finance—both reporting directly to Dajun Yang, MD, PhD, chairman and CEO.
Dr. Misra brings a deep scientific background in biology and significant experience in U.S. capital markets in the biopharmaceutical sector to the role of CFO. Mr. Huang’s background includes rich expertise in the global pharmaceutical industry and a wealth of experience in corporate management.
In a statement, Dr. Yang commented, “I am excited to welcome Veet and Eric to our senior management team. As an innovative biopharmaceutical company dual listed on the Hong Kong Stock Exchange and Nasdaq, Ascentage Pharma is entering a phase of notable growth. The addition of these seasoned executives will help accelerate the implementation of our global strategy of becoming a leading, fully integrated global biopharmaceutical company.”
